Palisade Capital Management

ElMindA Ltd. focuses on developing diagnostic and treatment tools for brain-related disorders through its innovative Brain Network Activation (BNA) technology. This platform integrates electroencephalography and event-related potential testing with machine learning and advanced algorithms to visualize and assess the brain's neural networks. By capturing electrophysiological patterns related to specific cognitive tasks, ElMindA creates high-resolution, three-dimensional representations of functional neural pathways, which can inform the understanding of various brain functions, including sensory processing, attention, and memory. The technology has applications in conditions such as mild traumatic brain injury, major depressive disorder, Parkinson's disease, and ADHD, aiming to enhance clinical practices in neuroscience. Founded in 2006, ElMindA operates from Herzliya, Israel, with an additional office in Glenview, Illinois.

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company based in Boulder, Colorado, established in 2009. The company specializes in identifying, developing, and commercializing prescription therapeutics aimed at treating debilitating skin diseases in the United States. Its lead product candidate, sofpironium bromide, is currently undergoing phase 3 clinical trials for the treatment of primary axillary hyperhidrosis. In addition to this, Brickell Biotech has a pipeline that includes potential novel therapeutics for hyperhidrosis and other common dermatological conditions. The company also has a collaboration agreement with AnGes, Inc. to develop a novel DNA vaccine candidate for COVID-19.

Neurologix, Inc. is a clinical-stage biotechnology company focused on the discovery and development of gene therapy treatments for serious disorders of the brain and central nervous system. The company aims to provide alternatives to traditional surgical and pharmacological interventions. Its primary areas of research include therapies for Parkinson's disease and epilepsy, conditions that significantly impact patients' quality of life. Additionally, Neurologix is involved in developing gene transfer therapies for other neurodegenerative and metabolic disorders, such as Huntington's disease, depression, and genetically-based obesity. Founded in 1999, Neurologix is headquartered in Fort Lee, New Jersey.

Send Word Now is the worldwide provider of enterprise communications services. Their easy-to-use, web-based and mobile solutions are deployed by businesses, government agencies, universities and non-profit organizations to ensure fast, effective communication when it is needed the most. Send Word Now was founded in 2001, by a group of individuals who recognized the need for immediate, reliable and multimodal crisis communications after the tragedies of September 11, 2001. Since that time, organizations across the globe have faced a multitude of natural and man-made disruptions, creating a heightened focus on business continuity, regulatory compliance, security and the ability to audit information flow. Further, today’s borderless business environment and increasingly mobile workforce have surfaced new needs for operations-focused communication and collaboration. Send Word Now is successfully transforming the way organizations communicate globally, both for emergency situations, and for every day, time-sensitive interactions. Their enterprise-class emergency notification system is capable of transmitting tens of thousands of voice and text messages in minutes, while providing a full audit trail for after action reporting and follow-up. Their mobile conferencing, collaboration and workflow solutions keep employees informed and connected to the people and information they need. And, everything is backed by their 100% Uptime reliability guarantee, and unmatched 24x7x365 customer support. In emergencies, or every day. When rapid, effective communication is essential for success, rely on Send Word Now for innovative, secure and reliable notification and collaboration solutions.

Mitralign is a privately held company based in a suburb of Boston, Massachusetts, focused on developing a catheter-based technology for the treatment of functional mitral regurgitation. The company has created an innovative system that mimics surgical annuloplasty by delivering surgical implants directly into the mitral annulus via a catheter. This process involves cinching the implants together to decrease the size of the mitral valve annulus and the valve opening. Mitralign's technology aims to provide a less invasive option for managing this life-threatening cardiac condition, enabling healthcare providers to effectively treat symptomatic functional mitral regurgitation through tissue-plication. The company is supported by prominent venture capitalists and has attracted investments from major cardiovascular device firms.

Shoe Sensation, Inc. operates a regional chain of family-oriented shoe stores across multiple states, including Arkansas, Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Tennessee, and West Virginia. Founded in 1974 and based in Jeffersonville, Indiana, the company provides a diverse selection of quality name-brand footwear for men, women, and children, catering to customers ranging from toddlers to seniors. The product range includes athletic shoes, running shoes, walking shoes, safety toe boots, heels, and sneakers, ensuring that the footwear needs of the entire family are met.

Ikonisys, Inc. specializes in designing and manufacturing medical diagnostic products aimed at cancer diagnosis and genetic disorder detection in the United States and Europe. The company offers a range of innovative products, including the Ikoniscope Robotic Microscope, which automates slide handling, scanning, and real-time image analysis to minimize human error in testing. Key applications include oncoFISH bladder for analyzing urine samples, oncoFISH her2 for assessing HER2 status in breast tissue, and oncoFISH PTEN for detecting PTEN gene deletions in prostate biopsies. Additionally, Ikonisys provides FISH scanning applications for both cell suspensions and various tissue sections, along with the IkoniWAN Gateway, a remote access solution for digital microscopy systems. Founded in 1999 and headquartered in New Haven, Connecticut, Ikonisys is committed to advancing diagnostic medicine through early and non-invasive disease detection, thereby enhancing patient management.

Language Weaver, Inc. specializes in developing and licensing automated translation solutions tailored for multinationals, government organizations, and translation providers. The company offers a range of products, including the LW Enterprise Translation Server, which facilitates on-site language translation within enterprises; the LW Custom Enterprise Translation Server, designed for specific domains such as information technology, automotive, medical, and finance; and LW Translation On Demand, an on-demand translation service. Additionally, Language Weaver provides LW Custom Translation On Demand, hosted on dedicated servers, as well as professional services that encompass software training, custom language pair development, and the preparation of parallel data to enhance translation accuracy and efficiency.

Achieve3000 delivers differentiated literacy solutions proven to increase reading comprehension and fluency, vocabulary and writing proficiency for students in grades 2 through 12. Through its proprietary software engine, the company uses the Internet to provide each student with an appropriate version of the same content based on his or her reading level. The company's products include KidBiz3000 (a reading and writing program for grades 2 through 5), TeenBiz3000 (a reading and writing program for grades 6 through 12) and Spark3000® (a reading and writing program for adult learners).

Versura is an online business-to-business exchange focused on enhancing opportunities within the higher education finance sector. The platform provides educational institutions with an Internet-based service that simplifies the process of selecting preferred lenders, allowing schools to customize loan programs to ensure optimal value for both their institutions and students. For lenders and financial institutions, Versura serves as an open digital marketplace that broadens market access, enabling them to connect with colleges and universities nationwide. Additionally, loan sellers can engage with buyers interested in acquiring all or part of their loan portfolios, facilitating a more efficient and expansive financial ecosystem in higher education.